ClinicalTrials.Veeva

Menu

Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients (NEURODIAB1)

U

University Hospital, Angers

Status

Completed

Conditions

Diabetes Mellitus Type 1

Treatments

Other: Microvascular assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT02538120
2012-A010008-35

Details and patient eligibility

About

This study aims to see whether or not the diabetes 1 patients have a neurovascular microcirculatory dysfunction using various microvascular tests which have been previously validated.

Microvascular responses will be assessed by Laser Speckle Contrast Imaging and expressed in Laser Speckle Perfusion Units (LSPU).

Full description

The investigators will compare microvascular responses between diabetes type 1 patients with matched control-subjects.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diabetes type 1 patients
  • Matched control-subjects

Exclusion criteria

  • Patients or subjects with anti-inflammatory drugs

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Diabetes type 1 patients
Active Comparator group
Description:
The intervention will be : Microvascular assessment with laser speckle contrast imaging
Treatment:
Other: Microvascular assessment
Matched control-subjects
Active Comparator group
Description:
The intervention will be : Microvascular assessment with laser speckle contrast imaging
Treatment:
Other: Microvascular assessment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems